ideayabio.com (IDYA) - Cash Funds per Single Share

Corporate emblem and logo of IDEAYA Corp (IDYA)

IDEAYA Biosciences' status as a pioneer in synthetic lethality makes the company a favorite in precision oncology. The cash per share metric visualizes this market optimism, where the 8.74 mark reflects the latest data. Capital growth is based on a unique scientific and technological ecosystem with strong pharma partners and a streamlined, high-speed biomaterial supply chain.

ideayabio.com (IDYA) - Cash per Single Share from 07/04/2022 to 11/20/2026

Comprehensive metric breakdowns and analytics for IDEAYA Corp (IDYA)

- market price and analyst price targets:
- cash position and cash flow details:
Comprehensive company analysis:IDEAYA Bio - IDYA
Flagship merchandise of IDEAYA Bio

For IDEAYA Biosciences (IDYA), whose development depends on clinical trial success and partner payments, the cash per share metric serves as an indicator of financial autonomy. This metric calculates the portion of liquid assets per share, determining the business's margin of safety and its ability to fund R&D without external borrowing, which is critically important for companies operating outside of macroeconomic cycles.